1 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
2 |
Carbidopa-levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
002 3件: 2 , 4 , 6 💬 |
3 |
Dalfampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
004 2件: 4 , 13 💬 |
4 |
Daraprim |
- |
- |
- |
- |
002 2件: 2 , 4 💬 |
5 |
Dexdor |
- |
- |
- |
- |
002 4件: 2 , 4 , 6 , 70 💬 |
6 |
Dexmedetomidine |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
7 |
Esketamine |
Esketamine |
1件: D07283 D07283 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 3件: 2 , 4 , 70 💬 |
8 |
Ketanest |
- |
- |
- |
- |
002 3件: 2 , 4 , 70 💬 |
9 |
Ketanest-s |
- |
- |
- |
- |
002 3件: 2 , 4 , 70 💬 |
10 |
Levetiracetam |
Levetiracetam |
1件: D00709 D00709 💬 |
SV2A 1件: SV2A 💬 |
ECM-receptor interaction 1件: ECM-receptor interaction |
002 4件: 2 , 4 , 6 , 13 💬 |
11 |
Levodopa |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
12 |
Pyrimethamine |
Pyrimethamine |
1件: D00488 D00488 💬 |
- |
- |
002 4件: 2 , 4 , 19, 65 💬 |
13 |
Stem cells |
- |
- |
- |
- |
002 4件: 2 , 4 , 96, 113 💬 |